NYSE:IQVLife Sciences
How Investors Are Reacting To IQVIA (IQV) Deepening Global Partnership With Kexing Biopharm
On August 11, 2025, Kexing Biopharm announced a comprehensive partnership with IQVIA to accelerate the global clinical development, regulatory approval, and commercialization of Kexing’s innovative drugs and biosimilars, with a focus on Europe and other regulated markets.
This collaboration highlights how IQVIA’s expertise in clinical trial design and regulatory strategy is being leveraged to help Kexing access international markets more efficiently.
We'll now explore how this expanded...